Medicine for treatment of primary aldosteronism

A technology for aldosterone and primary aldosteronism, which is applied in the field of drugs for the treatment of primary aldosteronism, which can solve problems such as side effects, drugs that cannot meet the needs of patients, and poor curative effect, and achieve quick results

Inactive Publication Date: 2019-04-30
史良侃
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are also many drugs for the treatment of primary aldosteronism, but most of them are not very effective, and m

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0010] The present invention will be further described in detail in conjunction with specific embodiments below.

[0011] A medicament for the treatment of primary aldosteronism, consisting of:

[0012] Sea wind rattan 10g-20g, sword flower 10g-20g, white back leaf root 10g-20g, stinky peony 10g-20g, Chinese peach leaf 10g-20g, auspicious grass 10g-20g, schisandra 10g-20g, hawthorn 10g-20g, astragalus 10g-20g and Cistanche 10g-20g.

[0013] As a preference, the medicine can be made into decoction.

[0014] Preferably, the drug can be made into tablets.

[0015] Preferably, the drug can be made into capsules.

[0016] The beneficial effect of the present invention is that it can effectively treat primary aldosteronism, has quick effect, has no side effects and is suitable for people of all ages and genders.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine for treatment of primary aldosteronism. The medicine is composed of the following ingredients: 10g- 20g of Caulis Piperis Kadsurae, 10g-20g of common nightblooming cereus, 10g-20g of mallotus apelta root, 10g-20g of Clerodendrum bungei, 10g-20g of Schefflera kwangsiensis, 10g-20g of Pink Reineckea Herb, 10g-20g of Chinese magnoliavine, 10g-20g of hawthorn, 10g-20g of Radix Astragali, and 10g-20g of Cistanche. The medicine has the beneficial effects of being effective for treating primary aldosteronism, has quick effect and no side effect, and is suitable forpeople of different ages and genders.

Description

technical field [0001] The invention belongs to the field of medicines, in particular to a medicine for treating primary aldosteronism. Background technique [0002] Primary aldosteronism is a common and multiple disease that occurs in all age groups, men, women, and children. At present, there are also many drugs for the treatment of primary aldosteronism, but most of them are not very effective, and many drugs will produce certain side effects. With the development of society, these drugs can no longer meet the needs of patients. Contents of the invention [0003] The technical problem to be solved by the present invention is to provide a drug for treating primary aldosteronism, which can conveniently treat primary aldosteronism and has no side effects. [0004] The technical scheme adopted in the present invention is: a kind of medicine for the treatment of primary aldosteronism, consists of the following components: [0005] Sea wind rattan 10g-20g, sword flower 10g...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/896A61P5/42A61P9/12A61P3/12
CPCA61K36/67A61K36/25A61K36/33A61K36/47A61K36/481A61K36/57A61K36/64A61K36/734A61K36/79A61K36/855A61K36/896A61K2300/00
Inventor 史良侃
Owner 史良侃
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap